A prediction tool incorporating the biomarker S-100B for patient selection for completion lymph node dissection in stage III melanoma

A prediction tool based on five parameters, including the biomarker S-100B, showed accurate risk stratification for NSN-involvement in SN-positive melanoma patients. If validated in future studies, this tool could help to identify patients with low risk for NSN-involvement.